Generate a tailored SOP for Dr. Bruno Larrivée. Improve your application with a focused, well-structured draft.
Bruno Larrivée, MD, PhD, leads the research unit on developmental and pathological angiogenesis. He is a full professor at the Department of Ophthalmology at the Université de Montréal. His research focuses on factors that mediate the quiescence and integrity of blood vessels during both physiological and pathological angiogenesis. His laboratory investigates the mechanisms underlying new blood vessel formation (angiogenesis) in the eye, which is frequently associated with various disorders that can severely impair vision and induce blindness. Current therapies for delaying undesirable ocular angiogenesis include laser surgery and inhibition of Vascular Endothelial Growth Factor (VEGF), a factor with significant pro-angiogenic properties. However, identifying alternative or complementary pathways to VEGF may lead to the development of effective and safe ocular angiogenesis inhibitors. Prof. Larrivée has received several awards for his research contributions, including the Senior Research Scholar award from the FRQS in 2021 and the Louise Rousselle Trottier Prize from the Canadian Heart Foundation in 2016.
Université de Montréal • Montréal, QC, Canada
Leading research in developmental and pathological angiogenesis.
Department of Pharmacology and Physiology - Research intensive with options in Neuropharmacology and Pharmacogenomics.